Early Detection Award – AACR, Lustgarten Foundation, The Mark Foundation
This major funding initiative supports transformative projects aimed at the early detection and diagnosis of recalcitrant cancers. The goal is to enable detection of these lethal cancers at stages where interventions are more effective. Applications should propose innovative approaches and may span multiple disciplines.
Eligibility Criteria:
-
Open to independent faculty researchers at non-profit institutions globally
-
2 to 4 investigators per project (1 PI + up to 3 co-investigators)
-
Focus must be on at least one of the following cancers:
-
Pancreatic cancer
-
Hepatobiliary cancers (e.g., HCC, bile duct, gallbladder)
-
Ovarian cancer
-
Glioblastoma
-
Upper GI cancers (gastric, esophageal)
-
Cancers from hereditary predisposition syndromes
-
-
Projects must focus on early detection, not cancer prevention
-
No overlapping funding allowed
Funding Details:
-
USD 2 million total per award
-
Two-year project duration
-
Covers direct and indirect costs (indirect capped at 10% of direct)
-
Successful projects may be eligible for additional support
-
Grantees will present at future events hosted by AACR and partners
Key Dates:
-
Full application invited: June 2025
-
Full application deadline: July 21, 2025
-
Notification of awards: October 2025
-
Grant start date: November 1, 2025
Further Information:
Visit the AACR Early Detection Award page or contact the program administrators at the AACR.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023